← Leaderboards
Heather Beryl Jaspan
Seattle Biomedical Research Institute
$18,555,020
Attributed
$27,674,797
Total exposure
14
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,674,797 · 14
By mechanism
R01$23,970,327 · 10
U01$2,123,526 · 1
R21$936,795 · 2
K08$644,149 · 1
Top collaborators
- Clive Maurice Gray12 shared
- Renee A. Heffron7 shared
- Jo-Ann Shelley Passmore6 shared
- Catherine A Blish5 shared
- Sinaye Ngcapu5 shared
- Arvind Varsani5 shared
- Jo-Ann Shelley Passmore4 shared
Most similar at Seattle Biomedical Research Institute
Same institution · by research overlap
- Ruobing Wang$5,389,064
- Gerard A Cangelosi$11,224,366
- Peter Lawaetz Andersen$2,263,044
- Michal Fried Fried$2,715,785
- Theonest Mutabingwa$2,825,211
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsSamplingCohortHiv InfectionsImmuneImmunityInflammationMicrobiomeMicrobialVaginaMucous MembraneCytokineWomanAfricanSouth AfricanTransmission ProcessInfantT-LymphocyteSouth AfricaLinkBirthLifeMothersPostpartum Period
Grant awards (62)
Bifidobacterium infantis supplementation in early life to improve immunity in infants exposed to HIV: a randomized, placebo-controlled, double-blind trial$761,676
R01 · FY2025 · HD · contact PI
Effect of Copper versus Levonorgestrel Intrauterine Devices on Mucosal Microbiota and Barrier Function: A Randomized Trial among Young African Women living with and at Risk for HIV$751,405
R01 · FY2025 · HD · contact PI
Influence of HIV infection on vaginal virome and risk of preterm birth in pregnant South African women$729,641
R01 · FY2025 · HD · contact PI
Bifidobacterium infantis supplementation in early life to improve immunity in infants exposed to HIV: a randomized, placebo-controlled, double-blind trial$82,137
R01 · FY2025 · HD · contact PI
Influence of HIV infection on vaginal virome and risk of preterm birth in pregnant South African women$70,988
R01 · FY2025 · HD · contact PI
Influence of HIV infection on vaginal virome and risk of preterm birth in pregnant South African women$816,376
R01 · FY2024 · HD · contact PI
Bifidobacterium infantis supplementation in early life to improve immunity in infants exposed to HIV: a randomized, placebo-controlled, double-blind trial$760,095
R01 · FY2024 · HD · contact PI
Influence of maternal virome and HIV status on infant gut virome, growth and immunity$729,928
R01 · FY2024 · HD · contact PI
MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN$325,093
R01 · FY2024 · HD
Combination biomarkers for preventing HIV and adverse birth outcomes in a South African pregnancy cohort: implications for infant health$278,459
R01 · FY2024 · HD
Influence of HIV infection on vaginal virome and risk of preterm birth in pregnant South African women$850,737
R01 · FY2023 · HD · contact PI
Influence of maternal virome and HIV status on infant gut virome, growth and immunity$798,741
R01 · FY2023 · HD · contact PI
Bifidobacterium infantis supplementation in early life to improve immunity in infants exposed to HIV: a randomized, placebo-controlled, double-blind trial$620,641
R01 · FY2023 · HD · contact PI
MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN$315,744
R01 · FY2023 · HD
Combination biomarkers for preventing HIV and adverse birth outcomes in a South African pregnancy cohort: implications for infant health$312,989
R01 · FY2023 · HD
Penile viral and bacterial microbiome, inflammation and HIV susceptibility$110,966
R21 · FY2023 · AI · contact PI
Influence of maternal virome and HIV status on infant gut virome, growth and immunity$769,959
R01 · FY2022 · HD · contact PI
Influence of HIV infection on vaginal virome and risk of preterm birth in pregnant South African women$750,682
R01 · FY2022 · HD · contact PI
Bifidobacterium infantis supplementation in early life to improve immunity in infants exposed to HIV: a randomized, placebo-controlled, double-blind trial$631,835
R01 · FY2022 · HD · contact PI
Penile viral and bacterial microbiome, inflammation and HIV susceptibility$410,966
R21 · FY2022 · AI · contact PI
MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN$334,425
R01 · FY2022 · HD
Combination biomarkers for preventing HIV and adverse birth outcomes in a South African pregnancy cohort: implications for infant health$325,543
R01 · FY2022 · HD
Influence of maternal virome and HIV status on infant gut virome, growth and immunity$745,594
R01 · FY2021 · HD · contact PI
Influence of HIV infection on vaginal virome and risk of preterm birth in pregnant South African women$677,120
R01 · FY2021 · HD · contact PI
Impact of HIV exposure, feeding status, and microbiome on immune ontogeny and vaccine responses in infants$420,985
U01 · FY2021 · AI
MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN$341,201
R01 · FY2021 · HD
Combination biomarkers for preventing HIV and adverse birth outcomes in a South African pregnancy cohort: implications for infant health$328,064
R01 · FY2021 · HD
Influence of maternal virome and HIV status on infant gut virome, growth and immunity$805,358
R01 · FY2020 · HD · contact PI
Mucosal injury from sexual practices: Behaviour and biology of South African adolescents$600,593
R01 · FY2020 · AI · contact PI
Effects of Hormonal Contraceptives on Genital Immunity and HIV Susceptibility$566,902
R01 · FY2020 · HD
Mucosal microbiome and vaccine responses in HIV-exposed African infants$438,572
R01 · FY2020 · AI · contact PI
Impact of HIV exposure, feeding status, and microbiome on immune ontogeny and vaccine responses in infants$423,352
U01 · FY2020 · AI
MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN$349,990
R01 · FY2020 · HD
Combination biomarkers for preventing HIV and adverse birth outcomes in a South African pregnancy cohort: implications for infant health$339,141
R01 · FY2020 · HD
Mucosal injury from sexual practices: Behaviour and biology of South African adolescents$583,595
R01 · FY2019 · AI · contact PI
Effects of Hormonal Contraceptives on Genital Immunity and HIV Susceptibility$564,259
R01 · FY2019 · HD
Mucosal microbiome and vaccine responses in HIV-exposed African infants$447,645
R01 · FY2019 · AI · contact PI
Impact of HIV exposure, feeding status, and microbiome on immune ontogeny and vaccine responses in infants$422,587
U01 · FY2019 · AI
Hormone induced mucosal susceptibility and HIV risk in South African adolescents$340,093
R01 · FY2019 · HD
Effects of Hormonal Contraceptives on Genital Immunity and HIV Susceptibility$533,196
R01 · FY2018 · HD
Mucosal injury from sexual practices: Behaviour and biology of South African adolescents$483,323
R01 · FY2018 · AI · contact PI
Mucosal microbiome and vaccine responses in HIV-exposed African infants$425,409
R01 · FY2018 · AI · contact PI
Impact of HIV exposure, feeding status, and microbiome on immune ontogeny and vaccine responses in infants$423,056
U01 · FY2018 · AI
Hormone induced mucosal susceptibility and HIV risk in South African adolescents$346,722
R01 · FY2018 · HD
Effects of Hormonal Contraceptives on Genital Immunity and HIV Susceptibility$241,581
R01 · FY2018 · HD
Effects of Hormonal Contraceptives on Genital Immunity and HIV Susceptibility$581,840
R01 · FY2017 · HD
Mucosal injury from sexual practices: Behaviour and biology of South African adolescents$485,861
R01 · FY2017 · AI · contact PI
Mucosal microbiome and vaccine responses in HIV-exposed African infants$448,870
R01 · FY2017 · AI · contact PI
Impact of HIV exposure, feeding status, and microbiome on immune ontogeny and vaccine responses in infants$433,546
U01 · FY2017 · AI
Hormone induced mucosal susceptibility and HIV risk in South African adolescents$327,344
R01 · FY2017 · HD
Effects of Hormonal Contraceptives on Genital Immunity and HIV Susceptibility$561,800
R01 · FY2016 · HD
Mucosal microbiome and vaccine responses in HIV-exposed African infants$464,580
R01 · FY2016 · AI · contact PI
Hormone induced mucosal susceptibility and HIV risk in South African adolescents$337,511
R01 · FY2016 · HD
Hormone induced mucosal susceptibility and HIV risk in South African adolescents$233,442
R01 · FY2016 · HD
Mechanisms of altered immune responses in HIV exposed infants$190,964
R21 · FY2016 · HD
Hormone induced mucosal susceptibility and HIV risk in South African adolescents$353,627
R01 · FY2015 · HD
Mechanisms of altered immune responses in HIV exposed infants$223,899
R21 · FY2015 · HD
Assessing feeding practices, immune activation, and HIV risk in African infants$128,430
K08 · FY2015 · HD · contact PI
Assessing feeding practices, immune activation, and HIV risk in African infants$128,430
K08 · FY2014 · HD · contact PI
Assessing feeding practices, immune activation, and HIV risk in African infants$128,835
K08 · FY2013 · HD · contact PI
Assessing feeding practices, immune activation, and HIV risk in African infants$129,227
K08 · FY2012 · HD · contact PI
Assessing feeding practices, immune activation, and HIV risk in African infants$129,227
K08 · FY2011 · HD · contact PI